NCT05669443

Brief Summary

Steep trendelenburg posture or pneumoperitoneum for surgery causes ventilation problems during surgery, so finding a way to overcome is a challenging task for anesthesiologists. In this study, for patients undergoing robot assisted laparoscopic prostatectomy under general anesthesia, anesthesia is going to perform by applying conventional positive end-expiratory pressure (PEEP 5cmH2O) or individually determined positive end-expiratory pressure values for each patient using electrical impedance tomography. We plan to compare intraoperative ventilation through arterial blood gas analysis to find out the way to improve intraoperative ventilation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable prostate-cancer

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 30, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

April 3, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2024

Completed
Last Updated

April 8, 2024

Status Verified

April 1, 2024

Enrollment Period

1.6 years

First QC Date

December 9, 2022

Last Update Submit

April 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • PaO2/FiO2

    PaO2/FiO2 is the ratio of arterial oxygen partial pressure (PaO2) to oxygen fraction (FiO2), and is a commonly used indicator for evaluating pulmonary ventilation and diagnosing lung damage. Using this index, it is possible to determine whether oxygen obtained through the lungs is well delivered to the blood or not. It can be easily obtained by arterial blood gas analysis without complicated formulas or graphs.

    end of surgery (before extubation)

Secondary Outcomes (6)

  • PaO2/FiO2

    15 minutes after intubation, 1 hour after pnemoperitoneum

  • ROI (region of interests)

    15 minutes after intubation, 1 hour after pnemoperitoneum, end of surgery (before extubation)

  • inhomogeneity index

    15 minutes after intubation, 1 hour after pnemoperitoneum, end of surgery (before extubation)

  • total amount of fluid administered during surgery

    end or surgery

  • total dose of vasopressor administered during surgery

    end of surgery

  • +1 more secondary outcomes

Study Arms (2)

conventional PEEP

EXPERIMENTAL

Apply of PEEP 5

Device: conventional PEEP

optimized PEEP

ACTIVE COMPARATOR

Apply of optimized PEEP derived using EIT (airtom®)

Device: optimized PEEP

Interventions

Maintain positive end expiratory pressure at 5 cmH2O throughout the surgery.

conventional PEEP

Immediately after induction of anesthesia, the patient remains unapplied to PEEP. After pneumoperitoneum + Trendelenburg posture, an appropriate PEEP value is derived using electrical impedance tomography (airtom®). And then derived value ( = optimized PEEP value) is applied until the end of the operation.

optimized PEEP

Eligibility Criteria

Age20 Years - 70 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age who are scheduled for robotic assisted laparoscopic prostatectomy at the Department of Urology, Gangnam Severance Hospital,
  • ASA-PS (American Society of Anesthesiology Body Rating) I-IlI,
  • Patients with a BMI of 35 kg/m2 or less

You may not qualify if:

  • Patients with lung disease
  • BMI \>35kg/m2
  • Patients for whom positive end-tidal pressure cannot be applied (large bullae, severe cardiac disease)
  • patient refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gangnam Severacne Hospital Yonsei University College of Medicine

Seoul, South Korea

RECRUITING

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Central Study Contacts

Chul-Ho Chang

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 9, 2022

First Posted

December 30, 2022

Study Start

April 3, 2023

Primary Completion

November 10, 2024

Study Completion

November 10, 2024

Last Updated

April 8, 2024

Record last verified: 2024-04

Locations